openPR Logo
Press release

Peanut Allergy Vaccine Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

10-30-2017 09:22 AM CET | Health & Medicine

Press release from: Pharamceutical

Peanut Allergy Vaccine Market – Global Industry Insights,

Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s immune system to build up an adaptive immunity to pathogens.

Food allergy is one of the major forms of allergies. Food allergies can be caused by cow’s milk, eggs, shellfish, and many other foods, including peanuts. However, peanut allergy is very prevalent in the present scenario, especially in children. Therefore, peanut allergy vaccine market is likely to gain significant traction in the near future. Peanut allergy vaccine is administered to patients who are detected with a probability of developing peanut allergy, so as to prevent occurrences of allergy attacks such as anaphylaxis in the future. According to a report published by National Centre for Biotechnology Information, allergy to peanuts as well as tree nuts (TNs) is the principal reason for fatal allergic reactions in the U.S., and the occurrences appear to be rising. In this 11 year follow up research, over 1% (around 3 million) people reported peanut or tree nut allergies and the condition has been on the rise, mainly amongst children. According to a report by Food Allergy Research and Education (FARE), peanuts caused the most number of allergies in the U.S., among all food allergens. Hence, peanut allergy vaccine market has a major potential for growth in this region during the forecast period (2016–2024).

Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/121

Peanut Allergy Vaccine Market Taxonomy

On the basis of end user, the global peanut allergy vaccines market is classified into:

Hospitals
Medical Practitioners
Government Agencies
Personal Clinics
Others
Government initiative towards creating awareness and regulatory approvals for peanut allergy vaccine is necessary for the growth of the market. Some of the other treatment methods for peanut allergy are oral immunotherapy and epinephrine treatment. However, neither of these treatments has gained significant momentum in the peanut allergy treatment market.

Peanut Allergy Vaccine Market Outlook – Increasing prevalence of peanut allergy and lack of proper treatment

Globally, incidence of peanut allergy is increasing supported by rising birth rate. The risk of peanut allergy is more prevalent in countries such as the U.K., Australia, and the U.S. According to American Academy of Allergy Asthma & Immunology, 30.4% of the children with food allergies suffered from multiple allergy attacks. Peanut allergy is such an epidemic condition in the U.S. that the federal Food Allergen Labeling and Consumer Protection Act (FALCPA) mandated that all packaged food sold in the U.S. that include peanuts as an ingredient have to prominently display the word 'Peanut' on the label. The only solution to peanut allergy is restraining a patient from having peanuts/peanuts containing products. Nevertheless, peanut vaccine is capable of curing the ailment from a very young age, without any restriction on food. Therefore, the future of the peanut allergy vaccine market is very promising. According to a research published by Asia Pacific Association of Allergy, Asthma and Clinical Immunology, the prevalence of food allergy (or peanut allergy) in Asia is low as compared to the West. Abundant use of peanuts in local cuisines in Asia Pacific is a major factor attributed to low incidence of peanut allergy in the region. As can be inferred from the report, the peanut allergy vaccine market is expected to grow at a considerable rate in the western part of the globe as compared to the eastern part.

Companies operating in the market in the current scenario are focusing on obtaining approval for their products from the respective regulatory bodies. The major companies operating in the market are Allergy Therapeutics, Zicam, Aravax, Immunomic Therapeutic, Inc., Astellas, and Aimmune.

Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/peanut-allergy-vaccine-market-121

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentnews.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peanut Allergy Vaccine Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 here

News-ID: 792270 • Views: 194

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases


More Releases for Allergy

Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon
Allergy Treatment Market 2018 Global Analysis By key Players – ALK, Stallergen …
Refractory Metals Market 2018 Wiseguyreports.Com adds “Refractory Metals Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “Refractory Metals Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Refractory Metals Market report also provides an in-depth survey of key players in the market which is based on the various objectives of
Global Allergy Immunotherapies (Allergy Immunotherapy) Market 2018 - Allergy The …
Accord Market, recently published a detailed market research study focused on the “Allergy Immunotherapies (Allergy Immunotherapy) Market” across the global, regional and country level. The report provides 360° analysis of “Allergy Immunotherapies (Allergy Immunotherapy) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of
Food Allergy Meeting 2018
Food allergy is body's immune response to certain food items whereas food intolerance is a body's chemical reaction towards a food item. Food allergies are on the rise particularly in school going children especially peanut allergy. Food allergies may be life threatening. Food intolerance is not involved with the immune system and does not cause severe allergic reactions. Food intolerance may lead to irritable bowel syndrome, asthma or chronic fatigue. Key
Allergy Immunotherapy Market Trend by 2023; Allergy Therapeutics, Circassia, DBV …
The Global Allergy Immunotherapy Market was around USD 2,100.0 million in 2016 and is expected to reach USD 4,324.7 million by 2023 which is a projected CAGR of 10.85% The global allergy immunotherapy market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future. Allergy immunotherapy is a disease-adapting therapy, effective for the treatment allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy,
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s